1. Home
  2. NWL vs DYN Comparison

NWL vs DYN Comparison

Compare NWL & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Newell Brands Inc.

NWL

Newell Brands Inc.

SELL

Current Price

$5.62

Market Cap

2.7B

Sector

Industrials

ML Signal

SELL

DYN

Dyne Therapeutics Inc.

SELL

Current Price

$16.18

Market Cap

2.8B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
NWL
DYN
Founded
1903
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Plastic Products
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.8B
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
NWL
DYN
Price
$5.62
$16.18
Analyst Decision
Hold
Strong Buy
Analyst Count
9
17
Target Price
$6.66
★ $35.73
AVG Volume (30 Days)
★ 5.1M
3.1M
Earning Date
10-30-2026
11-04-2026
Dividend Yield
★ 4.96%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.17
N/A
Revenue
★ $14,742,200,000.00
N/A
Revenue This Year
$1.75
N/A
Revenue Next Year
$1.48
N/A
P/E Ratio
$33.20
★ N/A
Revenue Growth
★ 11.14
N/A
52 Week Low
$3.07
$13.88
52 Week High
$7.13
$27.31

Technical Indicators

Market Signals
Indicator
NWL
DYN
Relative Strength Index (RSI) 49.18 34.55
Support Level $4.95 $14.34
Resistance Level $6.28 $19.54
Average True Range (ATR) 0.19 0.73
MACD 0.03 0.32
Stochastic Oscillator 66.90 49.27

Price Performance

Historical Comparison
NWL
DYN

About NWL Newell Brands Inc.

Newell Brands Inc is an American consumer goods company with a portfolio of brands, including Rubbermaid, Sharpie, Graco, Coleman, Rubbermaid Commercial Products, Yankee Candle, Paper Mate, FoodSaver, Dymo, EXPO, Elmer's, Oster, NUK, Spontex and Campingaz. The group is focused on delighting consumers by lighting up everyday moments. Its segments are Home and Commercial Solutions, Learning and Development, and Outdoor and Recreation. The group geographic areas are the United States, Canada, Europe, the Middle East and Africa, Asia Pacific, and Latin America.

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Share on Social Networks: